These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 34513879)
1. Fluorinated PLGA-PEG-Mannose Nanoparticles for Tumor-Associated Macrophage Detection by Optical Imaging and MRI. Zambito G; Deng S; Haeck J; Gaspar N; Himmelreich U; Censi R; Löwik C; Di Martino P; Mezzanotte L Front Med (Lausanne); 2021; 8():712367. PubMed ID: 34513879 [TBL] [Abstract][Full Text] [Related]
2. Targeted Imaging of CD206 Expressing Tumor-Associated M2-like Macrophages Using Mannose-Conjugated Antibiofouling Magnetic Iron Oxide Nanoparticles. Li Y; Wu H; Ji B; Qian W; Xia S; Wang L; Xu Y; Chen J; Yang L; Mao H ACS Appl Bio Mater; 2020 Jul; 3(7):4335-4347. PubMed ID: 34841220 [TBL] [Abstract][Full Text] [Related]
3. c-Met-Targeting Li D; Yang J; Xu Z; Li Y; Sun Y; Wang Y; Zou H; Wang K; Yang L; Wu L; Sun X Int J Nanomedicine; 2023; 18():2181-2196. PubMed ID: 37131548 [TBL] [Abstract][Full Text] [Related]
4. Novel Fluorinated Poly (Lactic-Co-Glycolic acid) (PLGA) and Polyethylene Glycol (PEG) Nanoparticles for Monitoring and Imaging in Osteoarthritis. Zerrillo L; Gupta KBSS; Lefeber FAWM; Da Silva CG; Galli F; Chan A; Veltien A; Dou W; Censi R; Di Martino P; Srinivas M; Cruz L Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562356 [TBL] [Abstract][Full Text] [Related]
6. Multitarget, multiagent PLGA nanoparticles for simultaneous tumor eradication and TME remodeling in a melanoma mouse model. Ramzy A; Soliman AH; Hassanein SI; Sebak AA Drug Deliv Transl Res; 2024 Feb; 14(2):491-509. PubMed ID: 37612575 [TBL] [Abstract][Full Text] [Related]
7. Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. Niu M; Valdes S; Naguib YW; Hursting SD; Cui Z Mol Pharm; 2016 Jun; 13(6):1833-42. PubMed ID: 27074028 [TBL] [Abstract][Full Text] [Related]
8. Alveolar Macrophages-Mediated Translocation of Intratracheally Delivered Perfluorocarbon Nanoparticles to Achieve Lung Cancer Wang H; Li X; Wang J; Wang J; Zou H; Hu X; Yang L; Shen P; A R; Wang K; Li Y; Yang J; Wang K; Yang L; Wu L; Sun X Nano Lett; 2023 Apr; 23(7):2964-2973. PubMed ID: 36947431 [TBL] [Abstract][Full Text] [Related]
9. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Song Y; Tang C; Yin C Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030 [TBL] [Abstract][Full Text] [Related]
10. High F-Content Perfluoropolyether-Based Nanoparticles for Targeted Detection of Breast Cancer by Zhang C; Moonshi SS; Wang W; Ta HT; Han Y; Han FY; Peng H; Král P; Rolfe BE; Gooding JJ; Gaus K; Whittaker AK ACS Nano; 2018 Sep; 12(9):9162-9176. PubMed ID: 30118590 [TBL] [Abstract][Full Text] [Related]
11. Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin. Niu M; Naguib YW; Aldayel AM; Shi YC; Hursting SD; Hersh MA; Cui Z Mol Pharm; 2014 Dec; 11(12):4425-36. PubMed ID: 25314115 [TBL] [Abstract][Full Text] [Related]
12. Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations. Scialla S; Hanafy MS; Wang JL; Genicio N; Costa Da Silva M; Costa M; Oliveira-Pinto S; Baltazar F; Gallo J; Cui Z; Bañobre-López M Int J Pharm; 2023 Feb; 632():122575. PubMed ID: 36603672 [TBL] [Abstract][Full Text] [Related]
13. In vivo clearance of Staal AHJ; Becker K; Tagit O; Koen van Riessen N; Koshkina O; Veltien A; Bouvain P; Cortenbach KRG; Scheenen T; Flögel U; Temme S; Srinivas M Biomaterials; 2020 Dec; 261():120307. PubMed ID: 32927288 [TBL] [Abstract][Full Text] [Related]
14. Development of elliptic core-shell nanoparticles with fluorinated surfactants for Wu Y; Minoshima M; Kikuchi K Front Chem; 2024; 12():1408509. PubMed ID: 38933928 [TBL] [Abstract][Full Text] [Related]
15. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy. Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417 [TBL] [Abstract][Full Text] [Related]
16. Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Zhu S; Niu M; O'Mary H; Cui Z Mol Pharm; 2013 Sep; 10(9):3525-30. PubMed ID: 23901887 [TBL] [Abstract][Full Text] [Related]
17. Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC. Sun Y; Yang J; Li Y; Luo J; Sun J; Li D; Wang Y; Wang K; Yang L; Wu L; Sun X Mol Cancer; 2022 Dec; 21(1):212. PubMed ID: 36457016 [TBL] [Abstract][Full Text] [Related]
18. A stable, highly concentrated fluorous nanoemulsion formulation for in vivo cancer imaging via Heaton AR; Lechuga LM; Tangsangasaksri M; Ludwig KD; Fain SB; Mecozzi S NMR Biomed; 2024 May; 37(5):e5100. PubMed ID: 38230415 [TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer. Sun X; Gao D; Gao L; Zhang C; Yu X; Jia B; Wang F; Liu Z Theranostics; 2015; 5(6):597-608. PubMed ID: 25825599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]